Glucose-dependent insulinotropic ploypeptide (GIP) and glucagon-like peptide (GLP)-1 are two main types of incretin. Both of them can increase glucose-dependent insulin secretion and play a hypoglycemic role. In recent years, the efficacy of GLP-1 receptor agonists for diabetes mellitus type 2 (T2DM) has been widely recognized, but the effect of GIP on T2DM is still unclear. When GIP is combined with GLP-1 in a single molecule double agonist, it can show a significant synergistic effect. This article summarized the role of GIP/GLP-1 dual receptor agonists in glycemic control in patients with T2DM and the new findings from preclinical and clinical studies to provide reference for clinical practice.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |